Joseph McEvoy, MD

Department of Psychiatry, Augusta University, Augusta, Georgia

  • 2Articles
  • 8.5KReads
  • 2015–2025Active
  • 6Collaborators
  • 5Citations

About

Joseph McEvoy, MD, is affiliated with the Department of Psychiatry at Augusta University in Augusta, Georgia. His publications from 2015 to 2025 focus on patient care in schizophrenia and schizoaffective disorders, including clinical trials evaluating brexpiprazole for co-occurring schizophrenia and substance use disorder, and asenapine dosing regimens. He has collaborated frequently with Amy Harrington, L. Fredrik Jarskog, Oliver Freudenreich, Robert Hamer, and Xiaoduo Fan.

Publications

JCP
Brexpiprazole for the Treatment of Co-Occurring Schizophrenia and Substance Use Disorder
Original Research

Brexpiprazole for the Treatment of Co-Occurring Schizophrenia and Substance Use Disorder

October 13, 2025

This pilot trial suggests that brexpiprazole might be beneficial in reducing substance craving and use and improve quality of life in this difficult-to-treat patient population.
, , , et al
JCP
Letter to the Editor

Asenapine Once Daily Versus Twice Daily: Impact on Patient Acceptance in a Randomized, Open-Label, 14-Day Clinical Trial

July 22, 2015

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe